Oxidative Stress and Antioxidant Imbalance in Ovulation Disorder in Patients with Polycystic Ovary Syndrome

Overview

Journal Front Nutr

Specialty Nutritional Sciences

Date 2022 Nov 17

PMID 36386912

Authors

Wenqian Li

Chang Liu

Qingmei Yang

Ying Zhou

Min Liu

Hongying Shan

Affiliations

Soon will be listed here.

Abstract

Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease that is characterized by oligo-ovulation or anovulation, hyperandrogenism, and polycystic ovaries observed using ultrasound with high clinical heterogeneity. At present, the etiology of PCOS is not clear but is thought to be related to genetic, metabolic, endocrine and environmental factors. Hyperandrogenism interacts with insulin resistance and overweight/obesity, forming a vicious cycle of mutual promotion and participating in the occurrence and progression of PCOS. Oxidative stress (OS) refers to the imbalance between the oxidation system and antioxidation system in the human body, which is associated with the occurrence and development of various diseases. Recent studies have shown that OS may be closely related to ovulation disorders in PCOS, and antioxidants can improve the oxidative stress state of PCOS. However, previous studies did not examine the effect of the interaction between OS and hyperandrogenism, insulin resistance or overweight/obesity on ovulation disorders in PCOS. This article reviews the interaction between OS and hyperandrogenism, insulin resistance and overweight/obesity; the effects of OS, hyperandrogenism, insulin resistance and overweight/obesity on ovulation disorders in PCOS; and the application of antioxidants in PCOS.

Citing Articles

The role of salivary antioxidant level in polycystic ovary syndrome women under assisted reproductive technology treatment: A case-control study.

Gholizadeh N, Koopaie M, Aleyasin A, Milani A, Aghahosseini M, Kharrazifard M Int J Reprod Biomed. 2025; 22(12):975-984.

PMID: 39968368 PMC: 11830924. DOI: 10.18502/ijrm.v22i12.18063.

The Role of the Liver in the Pathophysiology of PCOS: A Literature Review.

Alhermi A, Perks H, Nigi V, Altahoo N, Atkin S, Butler A Biomolecules. 2025; 15(1).

PMID: 39858445 PMC: 11764088. DOI: 10.3390/biom15010051.

Comparing the Effect of Heat Therapy and Mitochondrial-Targeted Antioxidants in Polycystic Ovarian Syndrome Phenotype Induced by Junk Food Consumption.

Amin S, Aolymat I, Hosny S, Latif N, Ibrahim W, ShamsEldeen A Reprod Sci. 2025; 32(2):343-357.

PMID: 39821756 DOI: 10.1007/s43032-024-01755-w.

Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress-apoptosis gene expression in PBMCs of women with PCOS.

Jabarpour M, Amidi F, Aleyasin A, Shabani Nashtaei M, Saedi Marghmaleki M J Cell Mol Med. 2024; 28(14):e18464.

PMID: 39036884 PMC: 11261353. DOI: 10.1111/jcmm.18464.

Minerals and the Menstrual Cycle: Impacts on Ovulation and Endometrial Health.

Kapper C, Oppelt P, Ganhor C, Gyunesh A, Arbeithuber B, Stelzl P Nutrients. 2024; 16(7).

PMID: 38613041 PMC: 11013220. DOI: 10.3390/nu16071008.

References

Gunning M, Petermann T, Crisosto N, van Rijn B, de Wilde M, Christ J . Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis. Hum Reprod Update. 2019; 26(1):103-117. PMC: 7007319. DOI: 10.1093/humupd/dmz036. View

Yin W, Falconer H, Yin L, Xu L, Ye W . Association Between Polycystic Ovary Syndrome and Cancer Risk. JAMA Oncol. 2018; 5(1):106-107. PMC: 6439760. DOI: 10.1001/jamaoncol.2018.5188. View

McCartney C, Prendergast K, Blank S, Helm K, Chhabra S, Marshall J . Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls. J Clin Endocrinol Metab. 2008; 94(1):56-66. PMC: 2630866. DOI: 10.1210/jc.2008-1252. View

Tauqir S, Israr M, Rauf B, Malik M, Habib S, Shah F . Acetyl-L-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial. Adv Ther. 2021; 38(7):3842-3856. DOI: 10.1007/s12325-021-01789-5. View

Uyanikoglu H, Sabuncu T, Dursun H, Sezen H, Aksoy N . Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study. Biomarkers. 2016; 22(7):643-647. DOI: 10.1080/1354750X.2016.1265004. View

Sies H, Jones D . Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020; 21(7):363-383. DOI: 10.1038/s41580-020-0230-3. View

Olivares-Reyes J, Arellano-Plancarte A, Castillo-Hernandez J . Angiotensin II and the development of insulin resistance: implications for diabetes. Mol Cell Endocrinol. 2009; 302(2):128-39. DOI: 10.1016/j.mce.2008.12.011. View

Khorshidi M, Moini A, Alipoor E, Rezvan N, Gorgani-Firuzjaee S, Yaseri M . The effects of quercetin supplementation on metabolic and hormonal parameters as well as plasma concentration and gene expression of resistin in overweight or obese women with polycystic ovary syndrome. Phytother Res. 2018; 32(11):2282-2289. DOI: 10.1002/ptr.6166. View

Zhang R, Liu H, Bai H, Zhang Y, Liu Q, Guan L . Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2016; 86(1):88-96. DOI: 10.1111/cen.13171. View

10.

Chen W, Pang Y . Metabolic Syndrome and PCOS: Pathogenesis and the Role of Metabolites. Metabolites. 2021; 11(12). PMC: 8709086. DOI: 10.3390/metabo11120869. View

11.

Szliszka E, Czuba Z, Domino M, Mazur B, Zydowicz G, Krol W . Ethanolic extract of propolis (EEP) enhances the apoptosis- inducing potential of TRAIL in cancer cells. Molecules. 2009; 14(2):738-54. PMC: 6254026. DOI: 10.3390/molecules. View

12.

Teede H, Misso M, Costello M, Dokras A, Laven J, Moran L . Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2018; 89(3):251-268. PMC: 9052397. DOI: 10.1111/cen.13795. View

13.

Escobar-Morreale H . Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018; 14(5):270-284. DOI: 10.1038/nrendo.2018.24. View

14.

Wolczynski S, Jozwik M, Szamatowicz M . Oxidative stress markers in preovulatory follicular fluid in humans. Mol Hum Reprod. 1999; 5(5):409-13. DOI: 10.1093/molehr/5.5.409. View

15.

Forman H, Zhang H . Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021; 20(9):689-709. PMC: 8243062. DOI: 10.1038/s41573-021-00233-1. View

16.

Gonzalez F, Considine R, Abdelhadi O, Acton A . Saturated Fat Ingestion Promotes Lipopolysaccharide-Mediated Inflammation and Insulin Resistance in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2018; 104(3):934-946. PMC: 6364509. DOI: 10.1210/jc.2018-01143. View

17.

Xu M, Wang Y, Li W, Huang C, Li J, Xie W . Ccrl2 deficiency deteriorates obesity and insulin resistance through increasing adipose tissue macrophages infiltration. Genes Dis. 2022; 9(2):429-442. PMC: 8843887. DOI: 10.1016/j.gendis.2020.08.009. View

18.

Ortega I, Villanueva J, Wong D, Cress A, Sokalska A, Stanley S . Resveratrol potentiates effects of simvastatin on inhibition of rat ovarian theca-interstitial cells steroidogenesis. J Ovarian Res. 2014; 7:21. PMC: 3940290. DOI: 10.1186/1757-2215-7-21. View

19.

Allen R, Tresini M . Oxidative stress and gene regulation. Free Radic Biol Med. 2000; 28(3):463-99. DOI: 10.1016/s0891-5849(99)00242-7. View

20.

Spaczynski R, Arici A, Duleba A . Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells. Biol Reprod. 1999; 61(4):993-8. DOI: 10.1095/biolreprod61.4.993. View